Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer|April 28, 2006
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of lifeJan Samuelsson, Hans Hasselbalch, Oystein Bruserud, et al.
Blood Advances|July 8, 2020
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding studyVikas Gupta, Denise Wolleschak, Hans Hasselbalch, et al.
European Journal of Haematology|April 16, 2019
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assayLasse Kjaer, Vibe Skov, Morten T Andersen, et al.
European Journal of Haematology|November 26, 2018
Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study GroupGunnar Birgegard, Jan Samuelsson, Erik Ahlstrand, et al.
Oncotarget|October 27, 2015
Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndromeChristen Lykkegaard Andersen, Helene Myrtue Nielsen, Lasse Sommer Kristensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 23, 2015
WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experienceAnn B Madelung, Henrik Bondo, Inger Stamp, et al.
Blood|July 5, 2005
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)Giovanni Barosi, Dominique Bordessoule, Jean Briere, et al.
International Journal of Cardiology|June 18, 2022
Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasmsCamilla Nordheim Solli, Sandra Chamat-Hedemand, Hanne Elming, et al.
Blood Advances|August 20, 2024
Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia veraAnders Lindholm Sørensen, Vibe Skov, Lasse Kjær, et al.
Cancer Research|April 14, 2011
FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosisChristophe Desterke, Chrystele Bilhou-Nabéra, Bernadette Guerton, et al.
Pageof 3